Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA12 (also referred to as LOC124900269 or ENSG00000212342) is a non-coding RNA identified within the small nucleolar RNA (snoRNA) class, typically involved in RNA modification processes such as the pseudouridylation of ribosomal RNA. Unlike receptors, enzymes, or other protein-based drug targets, SNORA12 does not encode a protein and is not considered a canonical therapeutic target in pharmacology[1][10]. There are no reported disease associations, drug interactions, safety considerations, or biomarkers related to this molecule in the standard biomedical literature or databases. The gene ENSG00000212342/LOC124900269/SNORA12 is a snoRNA gene, not a protein-coding gene, and does not fit conventional definitions of a therapeutic target. This makes it an incorrect choice if the intent was a druggable protein, receptor, enzyme, transporter, or related molecule[10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA12 (SNORA12).